dextroamphetamine has been researched along with Obesity in 82 studies
Dextroamphetamine: The d-form of AMPHETAMINE. It is a central nervous system stimulant and a sympathomimetic. It has also been used in the treatment of narcolepsy and of attention deficit disorders and hyperactivity in children. Dextroamphetamine has multiple mechanisms of action including blocking uptake of adrenergics and dopamine, stimulating release of monamines, and inhibiting monoamine oxidase. It is also a drug of abuse and a psychotomimetic.
(S)-amphetamine : A 1-phenylpropan-2-amine that has S configuration.
Obesity: A status with BODY WEIGHT that is grossly above the recommended standards, usually due to accumulation of excess FATS in the body. The standards may vary with age, sex, genetic or cultural background. In the BODY MASS INDEX, a BMI greater than 30.0 kg/m2 is considered obese, and a BMI greater than 40.0 kg/m2 is considered morbidly obese (MORBID OBESITY).
| Excerpt | Relevance | Reference |
|---|---|---|
| "To examine the use of the central nervous system stimulant dextroamphetamine sulfate to regulate appetite and subsequent weight gain in children treated for craniopharyngioma." | 9.10 | The use of dextroamphetamine to treat obesity and hyperphagia in children treated for craniopharyngioma. ( Krawiecki, N; Mason, PW; Meacham, LR, 2002) |
| "Sibutramine (BTS 54 524; N-[1-[1-(4-chlorophenyl)cyclobutyl]-3-methylbutyl]-N,N-dimethylamine hydrochloride monohydrate) is a novel 5-HT (serotonin) and noradrenaline reuptake inhibitor (SNRI) anti-obesity drug." | 8.80 | Sibutramine: a novel anti-obesity drug. A review of the pharmacological evidence to differentiate it from d-amphetamine and d-fenfluramine. ( Aspley, S; Cheetham, SC; Heal, DJ; Jackson, HC; Martin, KF; Prow, MR, 1998) |
| " This review addresses the following three topics: a brief discussion of older weight loss medications approved for short-term use (benzphetamine, phendimetrazine, diethylpropion, mazindol, and phentermine), as well as over-the-counter adrenergic drugs (phenylpropanolamine and ephedrine); recent clinical studies documenting the safety and efficacy of a new medication for obesity treatment, sibutramine, recently approved by the Food and Drug Administration for long-term use; and recent studies characterizing the valvulopathy associated with fenfluramine and dexfenfluramine, serotonergic medications for obesity which have been removed from the markets." | 8.80 | Use of sibutramine and other noradrenergic and serotonergic drugs in the management of obesity. ( Ryan, DH, 2000) |
| "A limited number of published case reports suggest a positive effect of dextroamphetamine, an adrenergic agonist affecting both the central nervous system (CNS) and peripheral nervous system, on physical activity and weight in patients with hypothalamic obesity (intractable obesity following CNS insult)." | 7.91 | Treatment of Hypothalamic Obesity with Dextroamphetamine: A Case Series. ( Denzer, C; Denzer, F; Lennerz, BS; Lustig, RH; Vollbach, H; Wabitsch, M, 2019) |
| "In a controlled study (the control group receiving pyribenzamine) it was observed that reserpine, in the dosage used, had no effect on weight loss in patients receiving d-amphetamine sulphate (Dexedrine(R)) and methyl cellulose (Cellothyl(R)) while on 1,000-calorie diets as compared with the control group." | 7.64 | Reserpine in weight reduction. The effect in obese patients on 1,000-calorie diets: a controlled study. ( SMITH, MC, 1959) |
| "To examine the use of the central nervous system stimulant dextroamphetamine sulfate to regulate appetite and subsequent weight gain in children treated for craniopharyngioma." | 5.10 | The use of dextroamphetamine to treat obesity and hyperphagia in children treated for craniopharyngioma. ( Krawiecki, N; Mason, PW; Meacham, LR, 2002) |
| "Sibutramine (BTS 54 524; N-[1-[1-(4-chlorophenyl)cyclobutyl]-3-methylbutyl]-N,N-dimethylamine hydrochloride monohydrate) is a novel 5-HT (serotonin) and noradrenaline reuptake inhibitor (SNRI) anti-obesity drug." | 4.80 | Sibutramine: a novel anti-obesity drug. A review of the pharmacological evidence to differentiate it from d-amphetamine and d-fenfluramine. ( Aspley, S; Cheetham, SC; Heal, DJ; Jackson, HC; Martin, KF; Prow, MR, 1998) |
| " This review addresses the following three topics: a brief discussion of older weight loss medications approved for short-term use (benzphetamine, phendimetrazine, diethylpropion, mazindol, and phentermine), as well as over-the-counter adrenergic drugs (phenylpropanolamine and ephedrine); recent clinical studies documenting the safety and efficacy of a new medication for obesity treatment, sibutramine, recently approved by the Food and Drug Administration for long-term use; and recent studies characterizing the valvulopathy associated with fenfluramine and dexfenfluramine, serotonergic medications for obesity which have been removed from the markets." | 4.80 | Use of sibutramine and other noradrenergic and serotonergic drugs in the management of obesity. ( Ryan, DH, 2000) |
| "A limited number of published case reports suggest a positive effect of dextroamphetamine, an adrenergic agonist affecting both the central nervous system (CNS) and peripheral nervous system, on physical activity and weight in patients with hypothalamic obesity (intractable obesity following CNS insult)." | 3.91 | Treatment of Hypothalamic Obesity with Dextroamphetamine: A Case Series. ( Denzer, C; Denzer, F; Lennerz, BS; Lustig, RH; Vollbach, H; Wabitsch, M, 2019) |
| "The hyperphagia characteristic of some types of obesity may result from a deficiency in one or more components of the systems controlling satiety which in rats may include the gastrointestinal hormone cholecystokinin (CCK)." | 3.66 | Cholecystokinin, amphetamine and diazepam and feeding in lean and obese Zucker rats. ( Baile, CA; McLaughlin, CL, 1979) |
| "In a controlled study (the control group receiving pyribenzamine) it was observed that reserpine, in the dosage used, had no effect on weight loss in patients receiving d-amphetamine sulphate (Dexedrine(R)) and methyl cellulose (Cellothyl(R)) while on 1,000-calorie diets as compared with the control group." | 3.64 | Reserpine in weight reduction. The effect in obese patients on 1,000-calorie diets: a controlled study. ( SMITH, MC, 1959) |
| "The dextroamphetamine group was superior in terms of behavioral treatment participation, extent of eating and exercise habit change, and weight loss." | 2.65 | Double-blind evaluation of reinforcing and anorectic actions of weight control medications. Interaction of pharmacological and behavioral treatments. ( Bigelow, GE; Griffiths, RR; Kaliszak, JE; Liebson, I, 1980) |
| "Fenfluramine was particularly effective in alleviating anxiety in patients who were initially higher in anxiety." | 2.64 | Emotional symptomatology in obese patients treated with fenfluramine and dextroamphetamine. ( Fisher, E; Hesbacher, P; Perloff, MM; Rickels, K; Rosenfeld, H, 1976) |
| " By measuring the brain function using computer period analysis of cerebral biopotentials, dose-efficacy relations were found (in the range of 25-75 mcg) which suggest the bioavailability of LHM at the CNS level." | 2.64 | Prediction of psychotropic properties of lisuride hydrogen maleate by quantitative pharmaco-electroencephalogram. ( Akpinar, S; Herrmann, WM; Itil, TM, 1975) |
| "Amphetamines evaluated were D- and D,L-amphetamine and methamphetamine." | 2.43 | NTP-CERHR monograph on the potential human reproductive and developmental effects of amphetamines. ( , 2005) |
| "Obesity is a leading public health problem worldwide." | 1.42 | Diet-induced obesity and diet-resistant rats: differences in the rewarding and anorectic effects of D-amphetamine. ( Cottone, P; Sabino, V; Steardo, L; Valenza, M, 2015) |
| "After an additional 12 days of treatment, weight gain decreased significantly accompanied by no appetite suppression." | 1.29 | Long-term treatment of obese Zucker rats with LY255582 and other appetite suppressants. ( Shaw, WN, 1993) |
| " Analysis of the dose-response curves indicated an ED50 for the obese rats of 0." | 1.27 | Effect of dopamine agonists and fenfluramine on discriminative behavior in obese and lean Zucker rats. ( Finkelstein, JA; Schechter, MD, 1985) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 71 (86.59) | 18.7374 |
| 1990's | 2 (2.44) | 18.2507 |
| 2000's | 6 (7.32) | 29.6817 |
| 2010's | 2 (2.44) | 24.3611 |
| 2020's | 1 (1.22) | 2.80 |
| Authors | Studies |
|---|---|
| van Schaik, J | 1 |
| Welling, MS | 1 |
| de Groot, CJ | 1 |
| van Eck, JP | 1 |
| Juriaans, A | 1 |
| Burghard, M | 1 |
| Oude Ophuis, SBJ | 1 |
| Bakker, B | 1 |
| Tissing, WJE | 1 |
| Schouten-van Meeteren, AYN | 1 |
| van den Akker, ELT | 1 |
| van Santen, HM | 1 |
| Denzer, C | 1 |
| Denzer, F | 1 |
| Lennerz, BS | 1 |
| Vollbach, H | 1 |
| Lustig, RH | 1 |
| Wabitsch, M | 1 |
| EDWARDS, DA | 1 |
| SWYER, GI | 1 |
| Valenza, M | 1 |
| Steardo, L | 1 |
| Cottone, P | 1 |
| Sabino, V | 1 |
| Geiger, BM | 1 |
| Haburcak, M | 1 |
| Avena, NM | 1 |
| Moyer, MC | 1 |
| Hoebel, BG | 3 |
| Pothos, EN | 1 |
| FINCH, JW | 1 |
| Mason, PW | 1 |
| Krawiecki, N | 1 |
| Meacham, LR | 1 |
| Saiz Ruiz, J | 1 |
| Saiz González, D | 1 |
| Antón Fructuoso, P | 1 |
| GELVIN, EP | 3 |
| McGAVACK, TH | 3 |
| KENIGSBERG, S | 2 |
| GOODMAN, EL | 1 |
| HOUSEL, EL | 1 |
| ROBERTS, E | 1 |
| ANDERSEN, H | 1 |
| QUAADE, F | 3 |
| FEINBLATT, HM | 1 |
| FEINBLATT, TM | 1 |
| FERGUSON, EA | 1 |
| KINARD, S | 2 |
| MILLS, LC | 2 |
| MOYER, JH | 2 |
| TERRELL, J | 2 |
| THORSEN, RK | 2 |
| VALBORG, A | 1 |
| ERLENDSSON, F | 2 |
| DEGROSSI, OJ | 1 |
| LOSSO, RH | 1 |
| ROTMISTROVSKY, JH | 1 |
| PATTERSON, M | 1 |
| FAZEKAS, JF | 1 |
| EHRMANTRAUT, WR | 1 |
| CAMPBELL, KD | 1 |
| NEGRON, MC | 1 |
| ERLENDSSON, V | 1 |
| POINDEXTER, A | 1 |
| SMITH, MC | 1 |
| GURTLER, J | 1 |
| SIMON, RI | 1 |
| KENNEDY, GC | 1 |
| MITRA, J | 1 |
| SOURS, JA | 1 |
| SANTI, R | 1 |
| FASSINA, G | 1 |
| SEATON, DA | 2 |
| ROSE, K | 1 |
| DUNCAN, LJ | 2 |
| MODELL, W | 1 |
| HUSSAR, AE | 1 |
| GILBERT, DB | 2 |
| HAMPSON, J | 1 |
| LORAINE, JA | 1 |
| STRONG, JA | 1 |
| JOHANNESSEN, SG | 1 |
| KUPERSMITH, IH | 1 |
| MOSSBERG, HO | 1 |
| RUNE FRISK, A | 1 |
| VIGLIONE, JP | 1 |
| SETTEL, E | 1 |
| Ismail, D | 1 |
| O'Connell, MA | 1 |
| Zacharin, MR | 1 |
| Fineberg, SK | 1 |
| Lorber, J | 1 |
| Resnick, M | 1 |
| Joubert, L | 1 |
| Ruedy, J | 1 |
| Check, JH | 1 |
| Gentlesk, MJ | 1 |
| Falanga, V | 1 |
| Hernandez, L | 1 |
| Monaco, AP | 1 |
| Miller, WC | 1 |
| Bigelow, GE | 2 |
| Griffiths, RR | 2 |
| Liebson, I | 2 |
| Kaliszak, JE | 1 |
| Stunkard, AJ | 2 |
| Deveaugh-Geiss, J | 1 |
| Pandurangi, A | 1 |
| Lewis, MJ | 1 |
| Kanarek, RB | 1 |
| Grinker, JA | 1 |
| Drewnowski, A | 1 |
| Enns, M | 1 |
| Kissileff, H | 1 |
| Shaw, WN | 1 |
| Heal, DJ | 1 |
| Aspley, S | 1 |
| Prow, MR | 1 |
| Jackson, HC | 1 |
| Martin, KF | 1 |
| Cheetham, SC | 1 |
| Ryan, DH | 1 |
| Kaliszak, J | 1 |
| Antelman, SM | 1 |
| Caggiula, AR | 1 |
| Black, CA | 1 |
| Edwards, DJ | 1 |
| McLaughlin, CL | 1 |
| Baile, CA | 1 |
| Rickels, K | 2 |
| Hesbacher, P | 2 |
| Fisher, E | 1 |
| Perloff, MM | 1 |
| Rosenfeld, H | 1 |
| Itil, TM | 1 |
| Herrmann, WM | 1 |
| Akpinar, S | 1 |
| de Wit, H | 1 |
| Uhlenhuth, EH | 1 |
| Johanson, CE | 1 |
| Schechter, MD | 1 |
| Finkelstein, JA | 1 |
| Stunkard, A | 1 |
| Yen, TT | 2 |
| Fuller, RW | 1 |
| Pearson, DV | 1 |
| Defelice, EA | 1 |
| Chaykin, LB | 1 |
| Cohen, A | 1 |
| Mathew, G | 1 |
| Lifshitz, F | 1 |
| Ahlskog, JE | 1 |
| Penick, SB | 1 |
| Abdallah, AH | 2 |
| Cabezas Cerrato, J | 1 |
| Catalán, E | 1 |
| Vila, T | 1 |
| Fernández-Cruz, A | 1 |
| Acton, JM | 1 |
| West, AP | 1 |
| Sproule, BC | 1 |
| Kaplan, NM | 1 |
| Jose, A | 1 |
| Bray, GA | 1 |
| York, DA | 1 |
| Sapeika, N | 1 |
| Zwarenstein, H | 1 |
| Kaplan, ER | 1 |
| London, AM | 1 |
| Schreiber, ED | 1 |
| Kattus, AA | 1 |
| Biscoe, BW | 1 |
| Dashe, AM | 1 |
| Davis, JH | 1 |
6 reviews available for dextroamphetamine and Obesity
| Article | Year |
|---|---|
NARCOLEPSY AND OTHER DISTURBANCES IN THE SLEEP-WAKING RHYTHM: A STUDY OF 115 CASES WITH REVIEW OF THE LITERATURE.
Topics: Black People; Cataplexy; Craniocerebral Trauma; Depression; Dextroamphetamine; Encephalitis; Halluci | 1963 |
NTP-CERHR monograph on the potential human reproductive and developmental effects of amphetamines.
Topics: Amphetamine; Animals; Attention Deficit Disorder with Hyperactivity; Behavior, Animal; Central Nervo | 2005 |
Anorectic agents lower a body weight set point.
Topics: Animals; Appetite Depressants; Appetite Regulation; Behavior Therapy; Body Weight; Dextroamphetamine | 1982 |
Sibutramine: a novel anti-obesity drug. A review of the pharmacological evidence to differentiate it from d-amphetamine and d-fenfluramine.
Topics: Animals; Biogenic Monoamines; Cyclobutanes; Dextroamphetamine; Energy Metabolism; Fenfluramine; Huma | 1998 |
Use of sibutramine and other noradrenergic and serotonergic drugs in the management of obesity.
Topics: Adrenergic Agents; Appetite Depressants; Cyclobutanes; Dexfenfluramine; Dextroamphetamine; Fenfluram | 2000 |
The treatment of obesity.
Topics: Amphetamine; Behavior Therapy; Chorionic Gonadotropin; Dextroamphetamine; Exercise Therapy; Hospital | 1972 |
10 trials available for dextroamphetamine and Obesity
| Article | Year |
|---|---|
The use of dextroamphetamine to treat obesity and hyperphagia in children treated for craniopharyngioma.
Topics: Analysis of Variance; Body Mass Index; Central Nervous System Stimulants; Child; Child Behavior Diso | 2002 |
A double-blind evaluation of an anorexiant, a placebo and diet alone in obese subjects.
Topics: Adolescent; Adult; Appetite Depressants; Dextroamphetamine; Diet, Reducing; Female; Humans; Obesity; | 1967 |
Double-blind evaluation of reinforcing and anorectic actions of weight control medications. Interaction of pharmacological and behavioral treatments.
Topics: Adult; Behavior Therapy; Body Weight; Clinical Trials as Topic; Dextroamphetamine; Double-Blind Meth | 1980 |
Emotional symptomatology in obese patients treated with fenfluramine and dextroamphetamine.
Topics: Adult; Anxiety; Body Weight; Clinical Trials as Topic; Depression; Dextroamphetamine; Emotions; Fema | 1976 |
Prediction of psychotropic properties of lisuride hydrogen maleate by quantitative pharmaco-electroencephalogram.
Topics: Adolescent; Adult; Aged; Biological Availability; Child; Child, Preschool; Clinical Trials as Topic; | 1975 |
Fenfluramine in the treatment of obesity.
Topics: Adult; Appetite Depressants; Body Weight; Clinical Trials as Topic; Constipation; Dextroamphetamine; | 1973 |
Double-blind clinical evaluation of mazindol, dextroamphetamine, and placebo in treatment of exogenous obesity.
Topics: Adult; Appetite Depressants; Body Weight; Clinical Trials as Topic; Consumer Behavior; Dextroampheta | 1973 |
Double-blind trial of anorectic agents.
Topics: Adolescent; Adult; Aged; Amphetamine; Appetite Depressants; Clinical Trials as Topic; Dextroamphetam | 1969 |
Thyroid as an adjuvant to amphetamine therapy of obesity. A controlled double-blind study.
Topics: Adult; Amphetamine; Clinical Trials as Topic; Dextroamphetamine; Drug Synergism; Female; Humans; Mal | 1970 |
A controlled study of the effects of group discussions and an anorexiant in outpatient treatment of obesity. With attention to the psychological aspects of dieting.
Topics: Adolescent; Adult; Body Weight; Clinical Trials as Topic; Dextroamphetamine; Diet, Reducing; Female; | 1966 |
66 other studies available for dextroamphetamine and Obesity
| Article | Year |
|---|---|
Dextroamphetamine Treatment in Children With Hypothalamic Obesity.
Topics: Adolescent; Child; Dextroamphetamine; Energy Metabolism; Humans; Hypothalamic Diseases; Obesity; Ret | 2022 |
Treatment of Hypothalamic Obesity with Dextroamphetamine: A Case Series.
Topics: Adolescent; Adult; Body Mass Index; Child; Cohort Studies; Dextroamphetamine; Exercise; Female; Heal | 2019 |
The comparative values of dextroamphetamine sulphate, dried thyroid gland and a placebo in the treatment of obesity.
Topics: Amphetamine; Amphetamines; Dextroamphetamine; Humans; Obesity; Placebos; Thyroid (USP); Thyroid Glan | 1950 |
Diet-induced obesity and diet-resistant rats: differences in the rewarding and anorectic effects of D-amphetamine.
Topics: Adipose Tissue; Animals; Appetite Depressants; Body Composition; Dextroamphetamine; Diet; Diet, High | 2015 |
Deficits of mesolimbic dopamine neurotransmission in rat dietary obesity.
Topics: Animals; Central Nervous System Agents; Corpus Striatum; Dextroamphetamine; Diet; Dopamine; Dopamine | 2009 |
The overweight obstetric patient with special reference to the use of dexedrine sulfate.
Topics: Dextroamphetamine; Female; Humans; Obesity; Overweight; Pregnancy; Pregnancy Complications; Sulfates | 1947 |
[Abuse potential of sibutramine].
Topics: Appetite Depressants; Central Nervous System Stimulants; Cyclobutanes; Dextroamphetamine; Female; Hu | 2003 |
The anorexigenic effect of sustained-release dexedrine preparations.
Topics: Amphetamine; Amphetamines; Appetite; Delayed-Action Preparations; Dextroamphetamine; Obesity | 1953 |
The effect of d-amphetamine sulfate in the treatment of the obese hypertensive patient.
Topics: Amphetamine; Amphetamines; Blood Pressure; Dextroamphetamine; Humans; Hypertension; Obesity; Vascula | 1954 |
Sustained release dexedrine: a comparison of various preparations in the management of obesity.
Topics: Amphetamine; Amphetamines; Delayed-Action Preparations; Dextroamphetamine; Disease Management; Obesi | 1954 |
D'amphetamine therapy in obesity or depression complicated by benign hypertension.
Topics: Amphetamine; Amphetamines; Depression; Depressive Disorder; Dextroamphetamine; Humans; Hypertension; | 1954 |
The effect of d-amphetamine on obese children.
Topics: Amphetamine; Amphetamines; Child; Dextroamphetamine; Humans; Infant; Obesity | 1954 |
Treatment of obesity with d-amphetamine hydrochloride and amobarbital.
Topics: Amobarbital; Amphetamine; Amphetamines; Barbiturates; Central Nervous System Stimulants; Dextroamphe | 1956 |
Use of d-amphetamine to curb the increased appetite and over-eating induced by reserpine therapy.
Topics: Amphetamine; Amphetamines; Appetite; Autonomic Nervous System Diseases; Dextroamphetamine; Feeding a | 1956 |
Use of d-amphetamine to curb the increased appetite and over-eating induced by reserpine therapy.
Topics: Amphetamine; Amphetamines; Appetite; Autonomic Nervous System Diseases; Dextroamphetamine; Feeding a | 1956 |
Use of d-amphetamine to curb the increased appetite and over-eating induced by reserpine therapy.
Topics: Amphetamine; Amphetamines; Appetite; Autonomic Nervous System Diseases; Dextroamphetamine; Feeding a | 1956 |
Use of d-amphetamine to curb the increased appetite and over-eating induced by reserpine therapy.
Topics: Amphetamine; Amphetamines; Appetite; Autonomic Nervous System Diseases; Dextroamphetamine; Feeding a | 1956 |
[Abuse of dextro-amphetamine; case with endocrinological disturbance].
Topics: Amphetamine; Amphetamines; Dextroamphetamine; Endocrine Glands; Humans; Mental Disorders; Obesity | 1956 |
[Abuse of dextro-amphetamine; case with endocrinological disturbance].
Topics: Amphetamine; Amphetamines; Dextroamphetamine; Endocrine Glands; Humans; Mental Disorders; Obesity | 1956 |
[Abuse of dextro-amphetamine; case with endocrinological disturbance].
Topics: Amphetamine; Amphetamines; Dextroamphetamine; Endocrine Glands; Humans; Mental Disorders; Obesity | 1956 |
[Abuse of dextro-amphetamine; case with endocrinological disturbance].
Topics: Amphetamine; Amphetamines; Dextroamphetamine; Endocrine Glands; Humans; Mental Disorders; Obesity | 1956 |
[Dexedrine treatment of obesity; report on ambulant reducing therapy of 83 women].
Topics: Amphetamine; Amphetamines; Dextroamphetamine; Exercise Therapy; Female; Humans; Obesity | 1957 |
[Effects of dextro-amphetamine in obese patients in comparison with placebos].
Topics: Amphetamine; Amphetamines; Dextroamphetamine; Obesity | 1957 |
[Effects of food & d-amphetamine on appetite & capillovenous glucose ratio in obese & normal subjects].
Topics: Amphetamine; Appetite; Blood Glucose; Dextroamphetamine; Food; Glucose; Humans; Obesity | 1957 |
A comparative study of phenmetrazine and dextro-amphetamine in a short-term reducing program in medical students.
Topics: Amphetamine; Amphetamines; Dextroamphetamine; Humans; Obesity; Phenmetrazine; Students, Medical; Sym | 1959 |
Comparative effectiveness of phenylpropanolamine and dextro amphetamine on weight reduction.
Topics: Amphetamine; Amphetamines; Dextroamphetamine; Humans; Obesity; Phenylpropanolamine; Sympathomimetics | 1959 |
[Ambulant treatment of obesity with lucofene and dexedrine].
Topics: Amphetamine; Amphetamines; Dextroamphetamine; Obesity | 1960 |
Appetite suppressant drugs: a controlled clinical comparison of benzphetamine, phenmetrazine, d-amphetamine and placebo.
Topics: Amphetamine; Amphetamines; Appetite Depressants; Benzphetamine; Dextroamphetamine; Humans; Obesity; | 1960 |
Reserpine in weight reduction. The effect in obese patients on 1,000-calorie diets: a controlled study.
Topics: Dextroamphetamine; Diet, Reducing; Humans; Obesity; Reserpine; Weight Loss | 1959 |
[Medically indicated weight reduction with "Dexten" and "Barbidex" (Nicholas)].
Topics: Dextroamphetamine; Humans; Obesity; Phenobarbital; Weight Loss | 1963 |
[Medical treatment of obesity].
Topics: Appetite Depressants; Dextroamphetamine; Obesity | 1963 |
Obesity as a depressive equivalent.
Topics: Aged; Depression; Depressive Disorder; Dextroamphetamine; Humans; Obesity | 1963 |
THE EFFECT OF D-AMPHETAMINE ON ENERGY BALANCE IN HYPOTHALAMIC OBESE RATS.
Topics: Dextroamphetamine; Energy Metabolism; Feeding and Eating Disorders; Hypothalamus; Metabolism; Obesit | 1963 |
DEXAMPHETAMINE AND LIPID MOBILIZATION IN OBESITY.
Topics: Blood Chemical Analysis; Dextroamphetamine; Fatty Acids; Lipid Metabolism; Lipid Mobilization; Obesi | 1964 |
A COMPARISON OF THE APPETITE SUPPRESSING PROPERTIES OF DEXAMPHETAMINE AND PHENTERMINE.
Topics: Amphetamine; Amphetamines; Appetite; Appetite Depressants; Biomedical Research; Dextroamphetamine; D | 1964 |
THE USES AND ABUSES OF APPETITE SUPPRESSANTS.
Topics: Amphetamine; Amphetamines; Appetite Depressants; Delayed-Action Preparations; Dextroamphetamine; Dru | 1965 |
FAILURE OF DEXTROAMPHETAMINE SULFATE TO INFLUENCE EATING AND SLEEPING PATTERNS IN OBESE SCHIZOPHRENIC PATIENTS: CLINICAL AND PHARMACOLOGICAL SIGNIFICANCE.
Topics: Appetite; Blood Pressure; Dextroamphetamine; Drug Therapy; Eating; Heart Rate; Humans; Obesity; Puls | 1965 |
INTRAMUSCULAR DEXTRO-AMPHETAMINE SULFATE IN THE TREATMENT OF INTRACTABLE OBESITY AND ITS COMPLICATIONS.
Topics: Dextroamphetamine; Drug Therapy; Humans; Injections, Intramuscular; Obesity | 1965 |
Phenmetrazine and dexamphetamine in the management of obesity.
Topics: Amphetamine; Amphetamines; Dextroamphetamine; Disease Management; Obesity; Phenmetrazine | 1960 |
[Loss of weight with dexedrine in medical practice].
Topics: Amphetamine; Amphetamines; Body Weight; Dextroamphetamine; Obesity | 1960 |
Value of ephedrine-ethlenediamine as an appetite depressant: comparison with d-amphetamine sulfate.
Topics: Amphetamine; Amphetamines; Appetite Depressants; Dextroamphetamine; Ephedrine; Ethylenediamines; Obe | 1960 |
Evaluation of the effect of d-amphetamine sulfate in the treatment of obesity in children.
Topics: Amphetamine; Amphetamines; Child; Dextroamphetamine; Humans; Obesity | 1950 |
Appetite control in pregnancy using combined prochlorperazine-dextroamphetamine.
Topics: Amphetamine; Amphetamines; Appetite; Appetite Regulation; Dextroamphetamine; Female; Obesity; Pregna | 1962 |
Combined d-amphetamine and chlordiazepoxide therapy in the emotionally disturbed obese patient.
Topics: Amphetamine; Amphetamines; Chlordiazepoxide; Dextroamphetamine; Mental Disorders; Obesity | 1963 |
Dexamphetamine use for management of obesity and hypersomnolence following hypothalamic injury.
Topics: Adolescent; Central Nervous System Stimulants; Child; Child, Preschool; Craniopharyngioma; Dextroamp | 2006 |
Dexedrine and weight reduction.
Topics: Dextroamphetamine; Humans; Obesity; Weight Loss | 1949 |
Anorexigenic drugs in perspective.
Topics: Amphetamine; Animals; Appetite Depressants; Chlorphentermine; Dextroamphetamine; Diethylpropion; Dru | 1967 |
Obesity in childhood.
Topics: Adolescent; Adult; Child; Child, Preschool; Dextroamphetamine; Diet Therapy; Humans; Obesity; Phenme | 1967 |
TDrug therapy in obesity.
Topics: Adolescent; Adult; Appetite Depressants; Central Nervous System; Child; Chlorphentermine; Dextroamph | 1967 |
Sympathomimetic amines in the treatment of chronic urticaria: two case reports.
Topics: Adult; Chronic Disease; Dextroamphetamine; Edema; Female; Humans; Obesity; Posture; Urticaria | 1984 |
Amphetamine-induced overeating and overweight in rats.
Topics: Animals; Anorexia; Dextroamphetamine; Feeding and Eating Disorders; Feeding Behavior; Female; Humans | 1981 |
Confusional paranoid psychosis after withdrawal from sympathomimetic amines: two case reports.
Topics: Adult; Aged; Depression; Dextroamphetamine; Diethylpropion; Female; Haloperidol; Humans; Male; Obesi | 1982 |
Enhanced amphetamine anorexia, but not drinking suppression in obese Zucker rats.
Topics: Animals; Body Weight; Dextroamphetamine; Drinking; Eating; Female; Obesity; Rats; Rats, Zucker | 1982 |
Effects of d-amphetamine and fenfluramine on feeding pattens and activity of obese and lean Zucker rats.
Topics: Animals; Dextroamphetamine; Diet; Drinking Behavior; Feeding Behavior; Fenfluramine; Male; Motor Act | 1980 |
Long-term treatment of obese Zucker rats with LY255582 and other appetite suppressants.
Topics: Albuterol; Animals; Appetite Depressants; Cyclohexanes; Dextroamphetamine; Drug Tolerance; Eating; E | 1993 |
Therapeutic self-medication as a context for drug abuse research.
Topics: Adult; Body Weight; Dextroamphetamine; Drug Prescriptions; Female; Fenfluramine; Humans; Male; Metha | 1978 |
Stress reverse the anorexia induced by amphetamine and methylphenidate but not fenfluramine.
Topics: Animals; Anorexia; Dextroamphetamine; Dose-Response Relationship, Drug; Feeding and Eating Disorders | 1978 |
Cholecystokinin, amphetamine and diazepam and feeding in lean and obese Zucker rats.
Topics: Animals; Body Weight; Cholecystokinin; Dextroamphetamine; Diazepam; Drug Interactions; Feeding Behav | 1979 |
The reinforcing properties of amphetamine in overweight subjects and subjects with depression.
Topics: Adult; Affect; Choice Behavior; Depression; Dextroamphetamine; Female; Humans; Male; Obesity; Person | 1987 |
Effect of dopamine agonists and fenfluramine on discriminative behavior in obese and lean Zucker rats.
Topics: Amphetamine; Animals; Appetite Depressants; Cocaine; Conditioning, Operant; Dextroamphetamine; Discr | 1985 |
The response of "obese" (ob-ob) and "diabetic" (db-db) mice to treatments that influence body temperature.
Topics: Animals; Apomorphine; Body Temperature; Body Temperature Regulation; Cold Temperature; Dextroampheta | 1974 |
Hyperuricemia in a child: a complication of treatment of obesity.
Topics: Acetone; Blood Chemical Analysis; Body Height; Body Weight; Child; Dextroamphetamine; Diabetes Melli | 1974 |
Overeating and obesity from damage to a noradrenergic system in the brain.
Topics: Animals; Appetite Regulation; Body Weight; Catecholamines; Denervation; Desipramine; Dextroamphetami | 1973 |
Comparative study of the anorexigenic activity of 5-(3,4-dichlorophenoxymethyl)-2-amino-2-oxazoline HCl and d-amphetamine in different species.
Topics: Animals; Appetite Depressants; Aurothioglucose; Blood Pressure; Body Weight; Cats; Dextroamphetamine | 1973 |
[Insulin secretion and hydrocarbon tolerance in essential obesity in women (influence of fenfluramine, phenformin and D-amphetamine)].
Topics: Administration, Oral; Blood Glucose; Body Weight; Dextroamphetamine; Evaluation Studies as Topic; Fe | 1973 |
Stimulation of locomotor activity of genetically obese mice by amphetamine.
Topics: Animals; Crosses, Genetic; Dextroamphetamine; Genotype; Male; Mice; Mice, Inbred C57BL; Motor Activi | 1973 |
Interaction of low-dose amphetamine use with schizophrenia in outpatients: three case reports.
Topics: Acute Disease; Adult; Ambulatory Care; Amphetamine; Dextroamphetamine; Dose-Response Relationship, D | 1974 |
Studies on food intake of genetically obese rats.
Topics: Animals; Cold Temperature; Dextroamphetamine; Diet; Environment; Feeding Behavior; Food Preferences; | 1972 |
Effect of fenfluramine and dexamphetamine on pyruvate kinase.
Topics: Animals; Dextroamphetamine; Enzyme Activation; Fenfluramine; In Vitro Techniques; Magnesium; Muscles | 1971 |
Spurious heart disease induced by digitalis-containing reducing pills.
Topics: Adult; Arrhythmias, Cardiac; Cathartics; Coronary Disease; Dextroamphetamine; Digitalis Glycosides; | 1968 |
Comparative study of anorectic activity of d-amphetamine, chlorphentermine and fenfluramine in aurothioglucose obese and non-obese mice.
Topics: Animals; Appetite; Appetite Depressants; Chlorphentermine; Dextroamphetamine; Fenfluramine; Fluorine | 1968 |
Intractable obesity and its complications. Treatment with intramuscular dextro-amphetamine sulfate.
Topics: Adult; Dextroamphetamine; Female; Humans; Injections, Intramuscular; Male; Middle Aged; Obesity | 1965 |